Efficacy and safety of the fixed‐ratio combination of insulin degludec and liraglutide by baseline glycated hemoglobin, body mass index and age in Japanese individuals with type 2 diabetes: A subgroup analysis of two phase III trials

Efficacy and safety of the fixed‐ratio combination of insulin degludec and liraglutide by baseline glycated hemoglobin, body mass index and age in Japanese individuals with type 2 diabetes: A subgroup analysis of two phase III trials

Abstract Aims/Introduction To assess efficacy and safety of insulin degludec/liraglutide (IDegLira) in Japanese participants with type 2 diabetes across different baseline characteristics. Materials and Methods Data from two randomized controlled trials were used: DUAL I Japan (n = 819 insulin‐naïve...

Full description

Bibliographic Details
Main Authors: Mitsuhisa Komatsu, Hirotaka Watada, Shizuka Kaneko, Bue F Ross Agner, Tomoyuki Nishida, Kohei Kaku
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Journal of Diabetes Investigation
Subjects:
Insulin degludec/liraglutide
Japan
Type 2 diabetes mellitus
Online Access:https://doi.org/10.1111/jdi.13525

Internet

https://doi.org/10.1111/jdi.13525

Similar Items